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Background: Chromobox 7 (CBX7) is a Polycomb family protein that extends the lifespan of normal human cells
via downregulating the expression of INK4a/ARF tumor suppressor locus. It was found that CBX7 expression was
upregulated in lymphoma, but downregulated in some other human malignancies. The role of CBX7 in most types
of cancer is still not clear. The purpose of this study is to investigate the role of CBX7 in gastric cancer.
Methods: The expression of CBX7 and its potential target protein p16(INK4a) in gastric cancer cell lines and gastric
tumors was assayed by Western blot analysis and immunohistochemistry(IHC). The correlations between CBX7
expression and p16(INK4a), clinicopathological characteristics, and prognosis were analyzed. Gastric cancer cell line
SGC-7901 was transfected with CBX7 siRNA expressing plasmids, and the expression of various proteins was
analyzed by Western blot analysis. Cellular senescence, anchorage independent growth, and cell migration assays
were performed to determine the functional role of CBX7 in gastric cancer cells.
Results: CBX7 was found to be overexpressed in gastric cancer cell lines and gastric tumors. Overexpression of
CBX7 in gastric cancer tissues correlated with patients’ age, clinical stage and lymph node metastasis. Knockdown
of CBX7 expression in gastric cancer cells led to increased cellular senescence, decreased cellular proliferation and
migration ability, accompanied by upregulation of p16(INK4a).
Conclusions: CBX7 acts as an oncogene in the carcinogenesis and progression of gastric cancer, and it may
regulate tumorigenesis, cell migration and cancer metastasis partially via p16(INK4a) regulatory pathway.
Background
Polycomb group (PcG) proteins are a class of epigenetic
regulators, which always form multiprotein complexes to
exert their functions in regulating cell proliferation, senes-
cence and tumorigenesis via well-known growth regula-
tory pathways [1]. More and more studies have implicated
the deregulation of different PcG proteins in carcinogen-
esis and neoplastic progression. Bmi-1 is one of the best
known PcG gene, which was initially identified for its abil-
ity to cooperate with c-Myc in lymphomagenesis and sub-
sequently was found to be overexpressed in many kinds of
human cancers and thus was accepted as an oncogene
[2-10]. Overexpression of Bmi-1 has been shown to
immortalize and transform normal human cells via
inhibiting cellular senescence, which constitutes a power-
ful barrier to oncogenesis [8,11]. INK4A/ARF tumor sup-
pressor locus is one of the most important cancer relevant
targets of Bmi-1. We have found that regulation of AKT/
PKB pathway is another important mechanism for Bmi-1
in breast and gastric cancers [8,10].
CBX7, another PcG protein, shares no homology with
Bmi-1 but was found to have similar functions and
mechanisms as Bmi-1 that inhibits cellular senescence
and extends the lifespan of normal human cells via
downregulating the expression of INK4a/ARF locus, and
cooperates with c-Myc in lymphomagenesis [7,8,11].
These data suggested that CBX7 functions as an onco-
gene like Bmi-1. However, several recent studies showed
that decrease or loss of CBX7 protein expression corre-
lated with a more aggressive phenotype in pancreatic,
thyroid and colorectal cancer, which suggested that
CBX7 might act as a potential tumor suppressor
[12-14]. The results are controversial and the functions
and mechanisms of CBX7 in caicinogenesis are still far
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different studies may due to the different cancer types.
Its role in different cancer types and different pathologi-
cal conditions needs to be clarified. Regulation of
INK4a/ARF locus by CBX7 also needs further confirma-
tion in cancer cells.
Gastric cancer is one of the most common malignan-
cies throughout the world, and mechanisms that under-
lie the carcinogenesis of gastric cancer are still poorly
understood. Recently we found that Bmi-1 plays an
important role in the carcinogenesis and progression of
gastric cancer and acts as an oncogene [10]. Does CBX7
also play a role in the carcinogenesis and progression of
gastric cancer needs to be studied. One newly published
paper revealed that CBX7 might be negatively regulated
by miRNA421 in gastric cancer cell line [15], though
the expression and function of CBX7 in gastric cancer
are still unclear. Here, we show that CBX7 is overex-
pressed in gastric cancer cell lines and gastric cancer
tissues, and its expression correlates with patients’ age,
clinical stage, lymph node metastasis, and poor prog-
nosis. We also report that knockdown of CBX7 expres-
sion in gastric cancer cell lines results in induction of a
senescence-like phenotype and reduction of transformed
properties, which is accompanied by upregulation of p16
(INK4a). These data suggest that CBX7 may act as an
oncogene in gastric cancer partially via regulation of
p16(INK4a).
Methods
Cellular reagents, molecular reagents, and methods
One immortalized human gastric mucosal epithelial cell
line (GES-1) and eight human gastric cancer cell lines
(MKN28, MKN45, KATOIII, NCI-N87, SNU-1, SNU-
16, SGC-7901, AGS) were preserved in Surgical Institu-
tion of Ruijin Hospital. These cell lines were cultured in
RPMI-1640 supplemented with 10% fetal bovine serum
(FBS) and antibiotics. CBX7 short interfering RNA
(siRNA) was designed and cloned in the retroviral vec-
tor pGCL-GFP obtained from GeneChem Inc. (Shang-
hai, China). The sequence of CBX7 siRNA (CBX7 i) was
as follows: CACCTTGCATGCACCTTGCTA. Nonsilen-
cing (NS)-siRNA was used as a control(Ctrl i). The ret-
roviruses were produced by transient transfection of the
retroviral vector together with pIK packaging plasmid
into 293 packaging cell line as described, and stable cell
lines expressing CBX7 i (CBX7 siRNA) or Ctrl i (control
siRNA) were generated by infection of the retroviruses
as described [16]. The senescence in gastric cancer cells
was determined by senescence-associated beta galactosi-
dase (SA-b-gal) assay as described [17]. Soft-agar assay
to determine the anchorage independent growth of cells
was done as described [18]. Transwell chamber (Corning
Costar, Cambridge, MA) migration assay was performed
as described [18] to detect cell migration ability.
Clinical samples
Seventy five paraffin-embedded human gastric cancer
tissue samples were collected from the archives of the
department of pathology for further immunohistochem-
ical analysis of different proteins’ expression. These
patients were diagnosed as gastric cancer and received
treatment in Xinhua hospital during 1999 and 2000.
Sixty nine patients received radical surgery, and followed
by 5-Fu based postoperative ajuvant chemotherapy for
patients with advanced stage(T3/4 or N1-3). Six patients
were found to have liver or peritoneal metastases during
operation and received palliative operation, followed by
5-Fu based palliative chemotherapy. The clinicalpatholo-
gic variables were obtained from the medical records
and the disease stages of the patients were classified
according to the 2002 UICC gastric cancer TNM staging
system. For the use of these clinical materials for
research purposes, prior patients’ consent and approval
from the Institute Research Ethics Committee was
obtained.
Immunological reagents, Western blot, and
Immunohistochemical analyses
CBX7 was detected by using a rabbit polyclonal anti-
body from Abcam (Cambridge, UK), and p16(INK4a)
was detected by a mouse monoclonal JC8 (Santa Cruz
Biotech, CA). Western blot analyses to detect the
expression of CBX7, p16(INK4a), and b-actin proteins
in gastric cancer cell lines were performed as described
[16]. Immunohistochemical (IHC) analyses to detect the
expression of CBX7, and p16(INK4a) in paraffin sections
were performed as described [19]. All slides were inter-
preted by two independent observers in a blinded fash-
ion. More than 10% of the cells were stained with
moderate or strong staining intensity was considered
positive. Otherwise, the sample was considered negative.
Statistical analysis
All statistical analyses were done by using the SPSS 15.0
software package. In the set of IHC assay of paraffin-
embedded tissue samples, the Pearson c
2 test was used
to estimate the correlations between CBX7 and p16
(INK4a), and clinicopathologic characteristics. Cumula-
tive survival curves were plotted by the Kaplan-Meier
method and the relationship between each of the vari-
ables and survival was assessed by Log-rank test in uni-
variate analysis. The parameters were then tested by
multivariate Cox proportional hazards model, which was
performed to identify independent variables for predict-
ing survival. A p value less than 0.05 was considered
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described as mean ± SD, and analyzed by Student’s
t-test.
Results
Overexpression of CBX7 in gastric cancer cell lines and
gastric tumor tissues
Firstly, we analyzed the expression of CBX7 in several
gastric cancer cell lines by western blot. Our results
showed that compared to GES-1, a normal immortal
human gastric mucosal epithelial cell line, 3 out of 8
gastric cancer cell lines expressed obviously high CBX7
at protein level (Fig 1A). Then, we studied the expres-
sion of CBX7 in normal gastric tissues and gastric
tumor tissues by IHC (Fig 1B). By IHC analysis, 25 of
75 (33.3%) paraffin-embedded archival gastric tumor
biopsies showed a positive staining for CBX7. These sec-
tions examined contained adjacent normal gastric tissue
in 60 cases, and only 1 of them (1/60, 1.7%) showed
positive staining of CBX7. No positive staining of CBX7
was detected in 10 normal gastric mucosal tissue sam-
ples (0/10, 0%). Compared with normal gastric mucosal
tissues, gastric tumor tissues expressed significantly
higher positive rate of CBX7 (p = 0.031).
The correlation between the expression of CBX7 with
clinicopathologic characteristics and prognosis
In paraffin-embedded archival gastric tumor samples,
there was a significant positive correlation between
CBX7 expression with clinical stage and lymph node
metastasis (N classification), and a significant negative
correlation between CBX7 expression and patients’ age.
The expression level of CBX7 was lower in patients with
older age, and higher in patients with late clinical stage,
or positive lymph node metastasis(Table 1), which sug-
gested that overexpression of CBX7 correlated with a
more aggressive phenotype in gastric cancer.
All the patients were followed up to get the survival
data. The median follow-up time was 52 months, and
f o r t yf i v ep a t i e n t sh a dd i e da tt h el a s tf o l l o w - u pt i m e .
The 5-year overall survival rate in patients with positive
Figure 1 The expression of CBX7 in gastric cancer cell lines
and gastric tumors. A) The expression of CBX7 and p16 proteins
in an immortalized human normal gastric epithelial cell line GES-1
and various gastric cancer cell lines as detected by Western blot
analysis. b-actin was used as a loading control. B) Examples of
nuclear staining of CBX7 in normal gastric tissues and gastric cancer
tissues by IHC detection: negative CBX7 expression in normal gastric
tissue (upper left); negative CBX7 expression (upper right), slight
positive CBX7 expression (lower left), and strong CBX7 expression
(lower right) in gastric cancer tissues. Tissue sections were stained
with CBX7-specific antibody and counterstained with hematoxylin
as described in experimental procedures (magnification: ×400).
Table 1 The correlations between CBX7 expression and
clinicopathologic variables, and p16 expression
Variables CBX7 n (%)
(-) (+) P value*
Gender
Male 34(68.0) 16(32.0)
Female 16(64.0) 9(36.0) 0.729
Age (years)
<60 15(50.0) 15(50.0)
≥60 35(77.8) 10(22.2) 0.012
Size(cm)
<4.5 26(65.0) 14(35.0)
≥4.5 24(68.6) 11(31.4) 0.743
Histology
Well differentiated 22(71.0) 9(29.0)
Poorly differentiated 28(63.6) 16(36.4) 0.507
T classification
T1/2 19(76) 6(24)
T3/4 31(62.0) 19(38.0) 0.605
LNM
Negative 31(77.5) 9(22.5)
Positive 19(54.29) 16(45.71) 0.035
Distant metastasis
Negative 48(82.76) 21(17.24)
Positive 2(56.52) 4(43.48) 0.071
Clinical stage
I/II 24(84.6) 5(15.4)
III/IV 26(60.0) 20(40.0) 0.02
p16
Negative 18(58.1) 13(41.9)
Positive 32(72.7) 12(27.3) 0.188
Abbreviations: LNM, lymph node metastasis. *Data were analyzed by the
c2-test and p < 0.05 was considered to be significant.
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negative CBX7 expression (25.0% vs. 35.0%, p < 0.001.
Fig 2). The results suggest that overexpression of CBX7
correlates with poor prognos i si np a t i e n t sw i t hg a s t r i c
cancer. However, multivariate Cox proportional hazards
model analyses, which included age, lymph node metas-
tasis, distant metastasis, clinical stage, CBX7 protein
expression and p16(INK4a) protein expression, showed
that only lymph node metastasis was an independent
prognostic indicator of overall survival, while CBX7
wasn’t the independent prognostic indicator (Table 2).
Knockdown of CBX7 expression induces senescence and
inhibits proliferation and migration of gastric cancer cells
We determined the transformation potential of control
and CBX7 knockdown SGC-7901 cells using anchorage-
independent growth assay, and determined the senes-
cence by SA-b-gal staining. Western blot analysis of
CBX7 indicted that CBX7 siRNA efficiently knock-
downed CBX7 expression (Fig 3A). Stable expression of
C B X 7s i R N Ai nS G C - 7 9 0 1c e l l sl e dt oa ni n c r e a s eo f
senescence and a decrease in colony formation in soft
agar (Fig 3B, C). Compared to control, the rate of senes-
cent cells was higher in CBX7 knockdown SGC-7901
cells (Fig 3B), and the soft agar colonies in CBX7 knock-
down SGC-7901 cells were less in frequency and also
smaller in size (Fig 3C).
As the expression of CBX7 in gastric cancer tissue
samples correlated with lymph node metastasis, we
hypothesized that CBX7 might also regulate cancer
metastasis. In support of this hypothesis, we used an
in vitro transwell chamber cell migration model to mea-
sure the effect of CBX7 on cell migration, which is one
of the important steps in cancer metastasis. Results
showed that the number of migrated cells decreased sig-
nificantly in CBX7 knockdown SGC-7901 cells, com-
pared to that in control cells (Fig 3D). Our results
suggest that CBX7 regulates cell migration and that
overexpression of CBX7 may contribute to cancer
metastasis.
p16(INK4a) is a target of CBX7 and may be one of the
mechanisms
To determine the possible mechanisms of CBX7 in gas-
tric carcinogenesis, we studied the relationship between
CBX7 and p16(INK4a), which is a down-stream target
of CBX7 during its controlling human normal cells life-
span. Firstly, we analyzed the expression of p16(INK4a)
in gastric cancer cell lines and gastric cancer tissues. We
found that the normal immortal human gastric mucosal
epithelial cell line GES-1 expressed high level of p16
(INK4a); while 3 of 8 gastric cancer cell lines expressed
lower level of p16(INK4a), and 5 of 8 gastric cancer cell
lines did not express detectable p16(INK4a). Cell lines
with low or no p16(INK4a) overexpressing CBX7 sug-
gested a negative correlation between the expression of
CBX7 and p16(INK4a) (Fig 1A). However, we found the
correlation between the expression of CBX7 and p16
(INK4a) in gastric cancer tissue samples by IHC analyses
was not significant (Table 1). Then, we examined the
expression of p16(INK4a) in control and CBX7 knock-
down SGC-7901 cells to determine the possible
mechanism of decreased transformed phenotype in gas-
tric cancer cell lines by knockdown of CBX7 expression.
We found that knockdown of CBX7 resulted in
increased p16(INK4a) expression (Fig 3A).
Discussion
More and more studies revealed that different PcG pro-
teins were involved in carcinogenesis and neoplastic
p r o g r e s s i o n .B m i - 1 ,a so n eo ft h eb e s tk n o w nP c G
genes, plays an important role in regulating cellular pro-
liferation, cellular senescence, tumorigenesis and
Figure 2 CBX7 expression in gastric cancer tissues correlated
with prognosis in univariate analysis. Kaplan-Meier survival
curves were plotted as cumulative survival vs months according to
CBX7 expression (negative and positive).
Table 2 Multivariate analysis of prognostic factors by the
Cox proportional hazards model in gastric carcinoma
Variables Hazard Ratio 95%CI P value
Lymph node metastasis 4.201 1.120-15.762 0.033*
Clinical stage 1.869 0.818-4.268 0.138
CBX7 1.323 0.678-2.584 0.412
P16 1.265 0.696-2.299 0.440
Age 1.009 0.984-1.035 0.472
Distant metastasis 1.801 0.682-4.758 0.235
* p < 0.05 was considered to be significant
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that INK4A/ARF locus and AKT/PKB pathway are two
important cancer relevant target of Bmi-1 in gastric and
breast cancers [8,10]. It was found that CBX7 shares
some similarities in functions and mechanisms with
Bmi-1 including inhibiting cellular senescence and
extending the lifespan of normal human cells via
downregulating the expression of INK4a/ARF tumor
suppressor locus [17,20,21]. Otherwise, CBX7 can initi-
ate T-cell lymphomagenesis and cooperate with c-Myc
to produce highly aggressive B-cell lymphomas in the
generation of transgenic mice overexpressing CBX7
[ 1 1 ] .M o r e o v e r ,i th a sa l s ob e e ns h o w nt h a tC B X 7
expression facilitates the survival of the mouse
Figure 3 Reduction of transformed phenotype by knockdown of CBX7 expression. A) CBX7 knockdown in SGC-7901 cells resulted in the
upregulation of p16 as determined by Western blot analysis. b-actin was used as a loading control. The level of p16 was quantified by
densitometric analysis of signal present in each lane and normalizing it to b-actin signal of respective lane using ImageJ 1.37v software (NIH,
Bethesda, USA). B) Knockdown of CBX7 expression in SGC-7901 cells resulted in increased cellular senescence (p < 0.01; upper panel, pictures of
SA-b-gal stained cells; lower panel, senescent cells were counted and plotted). C) Decreased number of colonies in soft agar in CBX7 knockdown
cells (p < 0.01; upper panel, pictures of colonies in soft agar; lower panel, the number of colony were counted and plotted). D) Transwell
migration assays using the Corning chamber showed that fewer number of cells migrated in SGC-7901 cells with CBX7 knockdown compared
with that in control (p < 0.01; upper panel, pictures of migrated cells; lower panel, the number of migrated cells were counted and plotted).
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CBX7 is also involved in carcinogenesis and acts as an
oncogene like Bmi-1.
However, several recent publications propose CBX7 as
a potential tumor suppressor. It was found that Loss of
CBX7 expression correlated with a more aggressive phe-
notype in thyroid carcinoma, pancreatic adenocarcinoma
and colorectal carcinoma [12-14]. The opposite role of
CBX7 in different studies may be due to the different
cancer types. Till now, studies concerning CBX7 are
limited and the functions and mechanisms of CBX7 in
caicinogenesis are still unclear. Its role in other cancer
types including gastric cancer needs to be clarified.
Recently we reported that Bmi-1 was overexpressed in
gastric cancer cell lines and gastric tumors and plays an
important role in the carcinogenesis and progression of
gastric cancer [10]. The function of CBX7 in the carci-
nogenesis and progression of gastric cancer needs to be
studied. In the present study we provide in vitro and
in vivo evidences to support the oncogenic role of CBX7
in gastric cancer development. Here we are the first
time to show that CBX7 is overexpressed in gastric can-
cer cell lines and gastric cancer tissues; and stable
knockdown of CBX7 expression in gastric cancer cells
can induce cellular senescence, which constitutes a
powerful barrier to oncogenesis [4], and inhibit prolif-
eration in in vitro study. Importantly, we found that
overexpression of CBX7 correlated with advanced clini-
cal stage and positive lymph node metastasis. Our
in vitro study also showed that knockdown of CBX7
expression inhibited the ability of migration in gastric
cancer cells. This is the first time to find that CBX7 reg-
ulates cellular migration in in vitro model, and provide
preliminary direct evidence for the possibility of CBX7
regulating the metastasis of cancer. All these results sug-
gest that CBX7 not only play important roles in tumori-
genesis, but may also be involved in the progression and
metastasis of gastric cancer. Our previous study showed
that Bmi-1 was an independent negative prognosis fac-
tor and patients with high Bmi-1 expression survived
significantly shorter than those with low and no Bmi-1
expression [10]. In the present study, using the same
patient samples, we also found that patients with posi-
tive CBX7 expression survived significantly shorter than
those with negative CBX7 expression. However, multi-
variate Cox proportional hazards model analysis showed
that lymph node metastasis, but not CBX7 is an inde-
pendent prognosis factor. Collectively, our data suggest
CBX7 shares similarities in functions with Bmi-1 in gas-
tric cancer, but we didn’tc o n f i r mC B X 7i sa ni n d e p e n -
dent prognosis factor as Bmi-1, which may be due to
the limited samples in the present study, or the function
of CBX7 may partially depend on Bmi-1, or its role is
not as important as Bmi-1 in gastric cancer.
It is interesting to note that the expression of CBX7
negatively correlated with age in this study. The positive
expression rate of CBX7 in old patients was significantly
lower than that in young patients. As CBX7 is capable
of regulating cellular proliferation and senescence [20],
and CBX7 expression is downregulated during replica-
tive senescence, the results suggest that cancer cells in
aged person might have lower proliferative ability, or
more cells in aged person are in the senescent state.
It’s already known that CBX7 regulates cellular senes-
cence and proliferation via Ink4a/Arf locus, which
encodes the cyclin-dependent kinase inhibitor p16
(INK4a) and tumor suppressor p19(Arf) [20]. However,
what’s the down-stream target and mechanism of CBX7
during gastric carcinogenesis is still unclear. In the pre-
sent study we found that knockdown of CBX7 resulted
in increased p16(INK4a) expression and was accompa-
nied by decreased transformed phenotype and migration
ability, which suggested regulation of p16(INK4a) might
be one of the important mechanisms of CBX7 in gastric
cancer. However, in our in vivo s t u d yw ed i dn o tf i n d
correlation between CBX7 and p16(INK4a) expression
in gastric tumor tissues. The discrepancy could be due
to the limited number of samples in our study, or other
co-exist genes regulating p16(INK4a) and promoter
methylation induced loss of p16(INK4a) expression
might interfere and influence the results of correlation
analysis. So the mechanisms of CBX7 in gastric cancer
still need to be further studied.
Conclusions
CBX7 plays a role in the carcinogenesis and progression
of gastric cancer and acts as an oncogene, and it may
regulate tumorigenesis, cell migration and cancer meta-
stasis partially via p16(INK4a) regulatory pathway.
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